can you die from glp 1 GLP-1 Medications: Everything Need to Know Ever wonder what happens when

Microdosing GLP-1 strategies for stopping semaglutide and tirzepatide treatment and maintaining weight loss

The GLP-1 landscape is experiencing a significant shift, with Canada leading the way

Medications from these distinct classes of pharmaceutical agents may be used as treatment by themselves (monotherapy) or in a combination of 2 or more drugs from multiple classes with different mechanisms of action

Glucagon-like-peptide-1 (GLP1) analogs may induce thyroid or pancreatic diseases in animals, raising questions about their use in diabetic patients

Muscle loss diagnoses also increased over time

Listen now (43 mins) |